JPMorgan raised the firm’s price target on WM (WM) to $265 from $255 and keeps an Overweight rating on the shares. The firm says WM is one of its “top defensive growth long ideas” for 2026. JPMorgan expects WM shares to re-rate on the company’s “robust” EBITDA accretion from renewable natural gas projects, a reduction in leverage, a resumption of buybacks, and as the “cloud of skepticism” on its healthcare growth subsides.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WM:
- The Week That Was, The Week Ahead: Macro & Markets, November 30
- ‘Attractive Entry Point’: Goldman Sachs Steps into the Environmental Services Arena With 2 New Buy Calls
- WM initiated with a Buy at DZ Bank
- WM initiated with a Buy at Goldman Sachs
- Insider Sales Shake Up Take-Two, Medical Properties, MP Materials, Waste Management, and Atlassian